Literature DB >> 18665149

International guidelines on access to biologic therapy: why the differences and which is best?

Chris Deighton1, Kimme Hyrich.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18665149     DOI: 10.1038/ncprheum0877

Source DB:  PubMed          Journal:  Nat Clin Pract Rheumatol        ISSN: 1745-8382


× No keyword cloud information.
  2 in total

1.  Treatment preferences in juvenile idiopathic arthritis - a comparative analysis in two health care systems.

Authors:  Boris Hugle; Johannes-Peter Haas; Susanne M Benseler
Journal:  Pediatr Rheumatol Online J       Date:  2013-01-15       Impact factor: 3.054

2.  Comparative Price Analysis of Biological Products for Treatment of Rheumatoid Arthritis.

Authors:  Manoela Manova; Alexandra Savova; Maria Vasileva; Silvia Terezova; Maria Kamusheva; Daniela Grekova; Valentina Petkova; Guenka Petrova
Journal:  Front Pharmacol       Date:  2018-09-20       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.